NCT01677598View on ClinicalTrials.gov

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries

CompletedOBSERVATIONAL

Enrollment

169

Participants

Timeline

Start Date

December 2, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Plaque Psoriasis

Interventions

DRUG

No intervention

No intervention will be administered during study. This will be an observational study in patients using ustekinumab as label-recommended or other/missed dose interval in Asia-Pacific countries

Trial Locations (9)

Unknown

Jakarta Pusat

Johor Bahru

Pulau Pinang

Singapore

Incheon

Seongnam-Si, Gyeonggi-Do

Seoul

Suwon

Taipei

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT01677598 - A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries | Biotech Hunter | Biotech Hunter